US Stock MarketDetailed Quotes
NVZMY NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10
- 62.760
- +0.020+0.03%
15min DelayClose Nov 1 16:00 ET
29.14BMarket Cap62.20P/E (TTM)
63.050High62.500Low4.21KVolume62.830Open62.740Pre Close264.31KTurnover0.00%Turnover Ratio39.65P/E (Static)464.36MShares72.50052wk High2.44P/B29.14BFloat Cap48.94052wk Low0.89Dividend TTM464.36MShs Float77.694Historical High1.41%Div YieldTTM0.88%Amplitude37.822Historical Low62.720Avg Price1Lot Size
NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.05%2.4B | 3.42%625.09M | 1.53%596.22M | -1.70%566.26M | 5.60%620.6M | 17.19%2.36B | 17.37%604.44M | 16.09%587.24M | 19.66%576.06M | 15.76%587.68M |
| Operating revenue | 2.05%2.4B | 3.42%625.09M | 1.53%596.22M | -1.70%566.26M | 5.60%620.6M | 17.19%2.36B | 17.37%604.44M | 16.09%587.24M | 19.66%576.06M | 15.76%587.68M |
| Cost of revenue | 2.60%1.1B | 2.30%287.59M | 1.42%275.36M | -1.45%252.58M | 8.88%284.59M | 25.81%1.07B | 24.20%281.12M | 27.43%271.5M | 28.87%256.31M | 23.04%261.37M |
| Gross profit | 1.59%1.31B | 4.38%337.49M | 1.62%320.86M | -1.90%313.68M | 2.97%336.01M | 10.86%1.29B | 12.01%323.33M | 7.83%315.74M | 13.17%319.75M | 10.52%326.31M |
| Operating expense | 2.20%706.23M | -8.10%192.16M | 17.28%162.43M | 4.32%177.92M | 1.24%174.92M | 8.48%691.06M | 6.16%209.1M | -4.83%138.51M | 14.16%170.56M | 19.09%172.77M |
| Selling and administrative expenses | 3.21%446.46M | 2.75%114.37M | -4.00%102.63M | 4.33%110.78M | 10.52%119.48M | 15.10%432.56M | -4.77%111.31M | 20.98%106.91M | 25.13%106.18M | 26.21%108.1M |
| -Selling and marketing expense | 4.22%317.66M | 3.31%81.63M | -2.52%71.05M | 7.51%79.76M | 9.06%85.78M | 17.09%304.79M | -3.43%79.01M | 18.83%72.88M | 27.71%74.19M | 33.25%78.65M |
| -General and administrative expense | 0.81%128.81M | 1.38%32.74M | -7.19%31.58M | -3.03%31.02M | 14.43%33.69M | 10.62%127.77M | -7.91%32.29M | 25.84%34.02M | 19.53%31.99M | 10.60%29.44M |
| Research and development costs | 0.88%270.91M | -0.38%71.15M | -3.43%61.68M | 3.32%69.15M | 4.71%69.4M | -0.58%268.56M | 3.85%71.42M | 9.17%63.87M | -0.25%66.93M | -12.44%66.28M |
| Operating profit | 0.89%599.58M | 27.23%145.33M | -10.62%158.42M | -9.00%135.76M | 4.92%161.09M | 13.77%594.29M | 24.58%114.22M | 20.34%177.24M | 12.06%149.19M | 2.24%153.54M |
| Net non-operating interest income expense | 18.52%-20.01M | 53.46%-23.76M | -32.65%17.66M | -342.63%-6.85M | -178.51%-7.11M | -75.64%-24.56M | -5,350.17%-51.05M | 749.85%26.22M | 169.96%2.82M | 48.65%-2.55M |
| Non-operating interest income | 400.39%12.09M | ---- | --1.47M | ---- | ---- | -0.18%2.42M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 69.74%23.24M | 69.57%16.15M | ---- | 245.14%5.1M | ---- | -0.18%13.69M | --9.52M | --1.34M | --1.48M | ---- |
| Total other finance cost | -33.28%8.86M | -55.17%19.7M | 41.27%-16.19M | 140.59%1.75M | 199.53%3.62M | 394.09%13.29M | 810.18%43.95M | -1,075.96%-27.57M | -277.68%-4.3M | -66.67%1.21M |
| Other net income (expense) | ||||||||||
| Special income (charges) | -190.80%-43.38M | -87.18%6.66M | -419.97%-21.68M | ---19.61M | ---8.86M | 93.12%47.78M | --51.95M | ---4.17M | --0 | --0 |
| -Less：Restructuring and merger&acquisition | 207.10%51.17M | ---- | ---- | ---- | ---- | -473.14%-47.78M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---7.79M | ---- | ---- | ---- | --8.86M | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -14.13%525.04M | -9.92%125.51M | -17.70%153.6M | -23.85%107.16M | -3.50%139.61M | 15.89%611.47M | 34.60%139.33M | 31.66%186.65M | 5.38%140.72M | -2.71%144.67M |
| Income tax | 0.08%116.85M | 38.41%30.95M | -7.27%29.3M | -20.07%24.71M | 0.69%32.08M | 11.48%116.76M | 12.55%22.36M | 11.35%31.6M | 15.52%30.91M | 7.24%31.86M |
| Net income | -17.49%408.18M | -19.16%94.55M | -19.83%124.3M | -24.92%82.45M | -4.68%107.53M | 16.99%494.7M | 39.83%116.97M | 36.74%155.05M | 2.84%109.81M | -5.20%112.8M |
| Net income continuous Operations | -17.49%408.18M | -19.16%94.55M | -19.83%124.3M | -24.92%82.45M | -4.68%107.53M | 16.99%494.7M | 39.83%116.97M | 36.74%155.05M | 2.84%109.81M | -5.20%112.8M |
| Minority interest income | 50.12%2.01M | 51.36%-393.69K | -796.50%-936.61K | -0.09%1.07M | 142.48%2.28M | 1,098.17%1.34M | -200.95%-809.45K | -0.02%134.47K | 1.08M | 941.15K |
| Net income attributable to the parent company | -17.67%406.17M | -19.39%94.95M | -19.16%125.24M | -25.16%81.37M | -5.92%105.25M | 16.63%493.36M | 40.35%117.78M | 36.79%154.91M | 1.83%108.73M | -5.99%111.86M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -17.67%406.17M | -19.39%94.95M | -19.16%125.24M | -25.16%81.37M | -5.92%105.25M | 16.63%493.36M | 40.35%117.78M | 36.79%154.91M | 1.83%108.73M | -5.99%111.86M |
| Basic earnings per share | -17.77%1.4667 | -19.69%0.3428 | -19.35%0.4522 | -25.07%0.2941 | -5.81%0.3799 | 17.19%1.7837 | 40.66%0.4268 | 37.14%0.5608 | 2.40%0.3925 | -5.36%0.4034 |
| Diluted earnings per share | -17.45%1.4613 | -19.51%0.3414 | -19.01%0.4509 | -24.90%0.2927 | -5.52%0.3786 | 17.24%1.7703 | 41.03%0.4242 | 37.51%0.5567 | 2.42%0.3898 | -5.40%0.4007 |
| Dividend per share | 86.26%1.3609 | 0.5594 | 0 | 0 | 9.70%0.8015 | 1.84%0.7306 | 0 | 0 | 0 | 1.84%0.7306 |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data